We are live on
!
Find out more
CCM
CAAS Capital Management Portfolio holdings
AUM
$934M
1-Year Est. Return
1.45%
This Fund
S&P 500
This Quarter
Est. Return
+26.63%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
+$6.2B
(+145%)
Cap. Flow
+$4.78B
Cap. Flow
% of AUM
45.54%
Top 10 Holdings %
Top 10 Hldgs %
28.07%
Holding
985
New
521
Increased
87
Reduced
60
Closed
171
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$153M |
| 2 |
Sunrun
RUN
|
+$94.3M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$83.8M |
| 4 |
Dynatrace
DT
|
+$67.2M |
| 5 |
Consolidated Edison
ED
|
+$56.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Solar
FSLR
|
+$71.8M |
| 2 |
10x Genomics
TXG
|
+$62.3M |
| 3 |
Caesars Entertainment
CZR
|
+$60.8M |
| 4 |
Denali Therapeutics
DNLI
|
+$53.1M |
| 5 |
PENN Entertainment
PENN
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.01% |
| 2 | Healthcare | 6.25% |
| 3 | Communication Services | 2.7% |
| 4 | Consumer Discretionary | 2.07% |
| 5 | Financials | 1.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
CALL
3M
MMM
$91.4B
| – | – |
-15,309
| Closed | -$2.05M |
|
877
PUT
Match Group
MTCH
$9.46B
| – | – |
-800,000
| Closed | -$88.5M |
|
878
Norwegian Cruise Line
NCLH
$9.07B
| – | – |
-11,722
| Closed | -$245K |
|
879
nCino
NCNO
$2.1B
| – | – |
-30,000
| Closed | -$2.39M |
|
880
Newmont
NEM
$100B
| – | – |
-7,100
| Closed | -$438K |
|
881
Netflix
NFLX
$305B
| – | – |
-16,500
| Closed | -$837K |
|
882
ServiceNow
NOW
$118B
| – | – |
-45,550
| Closed | -$4.74M |
|
883
Nurix Therapeutics
NRIX
$2.41B
| – | – |
-40,000
| Closed | -$1.4M |
|
|
NSA
884
DELISTED
National Storage Affiliates Trust
NSA
| – | – |
-238,877
| Closed | -$7.81M |
|
885
Norfolk Southern
NSC
$75.6B
| – | – |
-61,451
| Closed | -$13.2M |
|
886
Natera
NTRA
$38.7B
| – | – |
-15,299
| Closed | -$1.1M |
|
|
NTST
887
NETSTREIT Corp
NTST
$2.08B
| – | – |
-30,000
| Closed | -$548K |
|
888
CALL
NXP Semiconductors
NXPI
$56.5B
| – | – |
-1,100
| Closed | -$137K |
|
|
889
NXP Semiconductors
NXPI
$56.5B
| – | – |
-11,000
| Closed | -$1.62M |
|
890
Oracle
ORCL
$409B
| – | – |
-10,831
| Closed | -$645K |
|
|
891
PUT
Oracle
ORCL
$409B
| – | – |
-70,000
| Closed | -$4.18M |
|
892
Vaxcyte
PCVX
$7.73B
| – | – |
-20,000
| Closed | -$988K |
|
|
893
PENN Entertainment
PENN
$2.67B
| – | – |
-588,967
| Closed | -$42M |
|
894
CALL
Pfizer
PFE
$143B
| – | – |
-4,848
| Closed | -$169K |
|
|
895
PUT
Pfizer
PFE
$143B
| – | – |
-1,476
| Closed | -$51K |
|
896
Procter & Gamble
PG
$338B
| – | – |
-13,050
| Closed | -$1.82M |
|
897
Pliant Therapeutics
PLRX
$64.4M
| – | – |
-25,000
| Closed | -$566K |
|
898
Purple Innovation
PRPL
$39.2M
| – | – |
-6,983
| Closed | -$4.34M |
|
899
PayPal
PYPL
$49.5B
| – | – |
-15,260
| Closed | -$3.16M |
|
|
RAPT
900
DELISTED
RAPT Therapeutics
RAPT
| – | – |
-3,061
| Closed | -$789K |
|
Similar funds
CIG
TAM
WCF
CHP
SWC
KTA
LC
SBIA
CAAS Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, CAAS Capital Management held 985 positions worth $10.5B, up 145% from $4.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
CAAS Capital Management deployed $4.78B of net new capital in Q4 2020, opening 521 new positions and adding to 87 existing holdings. Its largest new stake was Sunrun: 1,519,346 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.8% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was First Solar, an estimated $71.8M trimmed.
- CAAS Capital Management's largest Q4 2020 buy was Sunrun: 1,519,346 shares worth $105M.
- CAAS Capital Management added most to Royalty Pharma in Q4 2020, an estimated $153M increase.
- CAAS Capital Management's biggest Q4 2020 reduction was First Solar, cutting an estimated $71.8M.
- CAAS Capital Management fully exited 10x Genomics in Q4 2020, selling an estimated $62.3M.
- CAAS Capital Management's ten largest holdings make up 28% of its $10.5B portfolio in Q4 2020.
- CAAS Capital Management opened 521 new positions and closed 171 in Q4 2020.
- CAAS Capital Management's portfolio value rose 145% quarter-over-quarter to $10.5B.
Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.